Ohio State University divulges new bacterial topoisomerase inhibitors for S. aureus infections
Feb. 15, 2024
Ohio State University has synthesized DNA topoisomerase II (bacterial) inhibitors reported to be useful for the treatment of Staphylococcus aureus infections.